Efficacy of a dietary supplement in dogs with osteoarthritis: A randomized placebo-controlled, double-blind clinical trial

被引:8
|
作者
Martello, Elisa [1 ]
Bigliati, Mauro [2 ]
Adami, Raffaella [3 ]
Biasibetti, Elena [4 ]
Bisanzio, Donal [5 ]
Meineri, Giorgia [6 ]
Bruni, Natascia [3 ]
机构
[1] Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Nottingham, England
[2] Ambulatorio Vernazza, Turin, Italy
[3] Candioli Pharma Srl, Beinasco, TO, Italy
[4] Ist Zooprofilatt Sperimentale Piemonte, Turin, Italy
[5] RTI Int, Washington, DC USA
[6] Univ Turin, Dept Vet Sci, Grugliasco, TO, Italy
来源
PLOS ONE | 2022年 / 17卷 / 02期
关键词
CHRONIC PAIN; CARPROFEN; QUESTIONNAIRE; COMBINATION; MANAGEMENT; COLLAGEN; OWNERS; JOINT;
D O I
10.1371/journal.pone.0263971
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study is a randomized, placebo-controlled, double-blinded trial performed to investigate the effects of a dietary supplement containing a mixture of Boswellia serrata Roxb., chlorophyll, green tea extract, glucosamine, chondroitin sulfate, hyaluronic acid, and further in the manuscript: non-hydrolised type II collagen in dogs with osteoarthritis (OA). A total of 40 dogs were enrolled in the study, they were randomly divided in control (CTR) and treatment (TRT) groups. The TRT group received the dietary supplement for 60 days. The CTR group received a placebo for the same number of days. All the subjects had veterinary evaluations during the trial and owners were requested to fill in questionnaires on chronic pain using the Helsinki Chronic Pain Index. The product was easy to administer and no side effects were reported. Combining results from veterinarian and owner evaluations, the tested product proved to be significantly beneficial in alleviating pain and in reducing the clinical signs in dogs with OA.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component A Randomized, Double-blind, Placebo-controlled Crossover Trial
    Schukro, Regina P.
    Oehmke, Matthias J.
    Geroldinger, Angelika
    Heinze, Georg
    Kress, Hans-Georg
    Pramhas, Sibylle
    ANESTHESIOLOGY, 2016, 124 (01) : 150 - 158
  • [42] Efficacy of naproxen in the management of patients hospitalized with COVID-19 infection: A randomized, double-blind, placebo-controlled, clinical trial
    Asadi, Masoomeh
    Sayar, Sara
    Radmanesh, Esmat
    Naghshi, Sina
    Mousaviasl, Sajedeh
    Jelvay, Saeed
    Ebrahimzadeh, Mona
    Mohammadi, Asma
    Abbasi, Samaneh
    Mobarak, Sara
    Bitaraf, Saeid
    Zardehmehri, Fatemeh
    Cheldavi, Ali
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (06)
  • [43] Clinical Efficacy of Perioperative Intravenous Dexmedetomidine and Lidocaine Combined Infusion for Thyroidectomy A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
    Guo, Hao
    Ao, Tingting
    Wang, Jiagao
    Zhang, Xi
    Zheng, Junwei
    Xiao, Yun
    Xue, Rui
    Kalika, Prakash
    Ran, Ran
    CLINICAL JOURNAL OF PAIN, 2022, 38 (04): : 264 - 270
  • [44] Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: A double-blind, randomized, multicenter, placebo-controlled clinical trial
    Okubo, Kimihiro
    Suzuki, Takamasa
    Tanaka, Ayaka
    Aoki, Hiroshi
    ALLERGOLOGY INTERNATIONAL, 2019, 68 (02) : 207 - 215
  • [45] Duloxetine for the Prevention of Oxaliplatin Induced Peripheral Neuropathy: A Randomized, Placebo-Controlled, Double-blind Clinical Trial
    Aghili, Mahdi
    Darzikolaee, Nima Mousavi
    Babaei, Mohammad
    Ghalehtaki, Reza
    Farhan, Farshid
    Razavi, Seyede Zahra Emami
    Rezaei, Saeed
    Esmati, Ebrahim
    Samiei, Farhad
    Azadvari, Mohaddeseh
    Farazmand, Borna
    Bayani, Reyhaneh
    Amiri, Ardavan
    JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (02) : 467 - 474
  • [46] Turpentine ointment in bacterial skin infections-a randomized, placebo-controlled, double-blind clinical trial
    Fuchs-Algrim, Joachim
    Lorenz, Horst
    Zimmermann, Christian
    Guennewich, Nils
    Schwarzensteiner, Ilona
    Kaiser, Peter-Michael
    Tronnier, Hagen
    COMPLEMENTARY MEDICINE RESEARCH, 2023, 30 (01) : 56 - 62
  • [47] A randomized, double-blind, prospective, placebo-controlled study of the efficacy of a diet supplemented with curcuminoids extract, hydrolyzed collagen and green tea extract in owner's dogs with osteoarthritis
    Comblain, Fanny
    Barthelemy, Nicolas
    Lefebvre, Michael
    Schwartz, Cedric
    Lesponne, Isabelle
    Serisier, Samuel
    Feugier, Alexandre
    Balligand, Marc
    Henrotin, Yves
    BMC VETERINARY RESEARCH, 2017, 13
  • [48] Efficacy and safety of an oral complementary medicine combination in people with symptomatic knee osteoarthritis: Protocol for the double-blind, randomized, placebo-controlled ATLAS trial
    Shahid, Arashi
    Liu, Xiaoqian
    Bracken, Karen
    Christensen, Robin
    Deveza, Leticia Alle
    Collins, Simone
    Harnett, Joanna
    Hunter, David J.
    Mclachlan, Andrew J.
    Robbins, Sarah
    Bowden, Jocelyn L.
    OSTEOARTHRITIS AND CARTILAGE OPEN, 2024, 6 (04):
  • [49] Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial
    Mansouri, P.
    Farshi, S.
    Hashemi, Z.
    Kasraee, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (01) : 209 - 217
  • [50] Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety
    Archer, David F.
    Dupont, Caroline M.
    Constantine, Ginger D.
    Pickar, James H.
    Olivier, Sophie
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (03) : 238.e1 - 238.e10